^{Heart Disease & Interventional Cardiology}

Oleksii is a serial entrepreneur and investor with twenty-five years experience. He creates twelve companies and do couple exits while. His professional background is business and team development, software/hardware engineering, sales, and finance. Last eight years he is focusing on healthcare area with a company called HeartIn. Oleksii's company creates a unique smart t-shirt with build in sensors, that brings wellness solutions and cardio-diagnostic to the mass market. The product has user-friendly comfortable design and costs just $160. On the wearable market now dominate devices with very low accuracy measurement HR/HRV and no solutions for mass preventive diagnostic. Those problems a team of HeartIn likes to solve.

Cardiology

Dr. Abouelmagd has been a cardiologist for many years; he is currently working as a registrar of cardiovascular medicine at Mouwasat Hospital, Riyadh, KSA. He received his MBBCh degree and ranked the 2nd in his class with “Excellent with an honorary degree” in 2010. He finished his residency in cardiovascular medicine and received his M.Sc degree at faculty of medicine, Al Azhar University, Cairo, Egypt He is in the pathway of Membership of the Royal Colleges of Physicians of the United Kingdom and ongoing to be an associate lecturer of cardiovascular medicine at faculty of medicine, Al Azhar University, Cairo, Egypt.

Dr. Abouelmagd subspecialty interests include non-invasive cardiology, cardiac imaging especially Echocardiography

Ljudmila Stojanovich received her Ph.D. in Medicine, with the thesis “Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus” in 1999. She is the scientific director in the Bezhanijska Kosa, University Medical Center of Belgrade University, where she is currently a Full Research Professor. Dr. Stojanovich’s research focuses on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She is an author of three monographs and of about 250 articles on various aspects of Autoimmune Rheumatic disorders, published in international and domestic journals and in conference proceedings.

Cardiology

Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, Moscow, Russia. In 2001, finished the PostDoc Research Fellowship Program and maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1985 through 1987, worked at Inst of Med Enzymology, USSR Academy of Medical Sciences. From 1987 through 1989, was a senior Researcher, Koltzov Inst of Developmental Biology, USSR Academy of Sciences. From 1989 through 1995, was being a Head of the Lab of Clinical Immunology and Immunobiotechnology, Helmholtz Eye Research Inst in Moscow. From 1995 through 2004, was being a Chairman of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI) and the Immunologist-in-Chief of the Moscow Regional Ministry of Health. In 1993-1996, was an Executice Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. Dr Suchkov is a Co-Supervisor over the Russian-American Agreement on scientific and clinical collab-oration in the field of ocular immunology between Russian Academy of Sciences and National Insti-tutes of Health (NIH); in 1991-1995 – a member of The Reciprocal Exchange Fellowship Program between Russian Immunological Society and British Society for Immunology. Dr Suchkov is a member of the Editorial Boards of many international journals including EPMA Jour-nal (Springer, Brussels) and “Personalized Medicine Universe” (Elsevier, Japan).

Medicine, Biomedical Science

Marco Picichè (MD, Ph.D.) graduated with a degree in medicine from the University of Florence in 1995 and completed his cardiac surgery residency at the Tor Vergata University of Rome in 2000, both summa cum laude. He held regular teaching appointments at the university of Montpellier school of medicine, obtained certification by the French Board in cardiac surgery (Paris, 2007), earned his research master in surgical science (Paris, 2007), and received a university diploma in vascular surgery (Paris, 2007). In Canada he authored a research project on the occlusion of the internal mammary arteries as an alternative method of myocardial blood supply (2008, Laval University). In May 2009 he had the honor of opening the 44th Congress of the European Society for Surgical Research with a lecture on ‘‘The history of surgical research.’’ In September 2011 he received a doctor of philosophy (Ph.D.) in therapeutic innovations from Paris-Sud University. He is the Editor in Chief of the book : « Dawn and evolution of cardiac procedures : research avenues in cardiac surgery and interventional cardiology » (Springer-Verlag publishing house, September 2012). He patented a new surgical instrument. Currently he is a cardiac surgeon in Italy.

Cardiology

Camelia Nicolae, PhD is currently the Assistant Professor at Internal Medicine and Cardiology Department, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania. She has been working in the Coronary and Intensive Care Unit since graduation. In clinical activity, she was interested in diagnosis and treatment of acute coronary syndrome, acute cardiac failure and pulmonary thromboembolism. She had a special preoccupation about ventricular remodelling post-acute myocardial infarction, which was reflected in her doctoral thesis. After the publication of the latest cardiology guidelines about stable coronary ischemic disease, she developed a constant interest in the high incidence and prevalence of this pathology “in real life”. Dr. Nicolae is constantly searching diagnostic solutions for early identification of coronary ischemic disease in different subgroups of general population with high cardiovascular risk, that don’t have a detailed approach accordingly to current protocols. In her career, she sustained and published over 70 scientific papers and original studies and in the last three years public conferences were mainly focused on stable coronary ischemic disease.

Cardiology